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Signaling path of the action of AVP on distal K+ secretion.
Background. Previous studies from our laboratory have
shown that luminal perfusion with arginine vasopressin (AVP)
stimulates distal tubule secretory potassium flux (JK) via V1 re-
ceptors (Am J Physiol 278:F809–F816, 2000). In the present
work, we investigate the cell signaling mechanism of this
process.
Methods. In vivo stationary microperfusion was performed in
rat cortical distal tubules and luminal K+ was measured using
double K+ resin/reference microelectrodes.
Results. In control conditions, JK was 0.71 ± 0.05 nmol.
cm−2.second−1; this process was inhibited (14%) by 10−5 mol/L
8-bromo-cyclic adenosine monophosphate (cAMP), and in-
creased by 35% with 10−8 mol/L phorbol ester [phorbol
12-myristate 13-acetate (PMA), which activates protein kinase
C (PKC)]. During luminal perfusion with 10−11 mol/L AVP, JK
increased to 0.88 ± 0.08 nmol.cm−2.seconds−1. In the presence
of 10−11 mol/L AVP, JK was not affected by 10−4 mol/L H89, a
blocker of protein kinase A (PKA), but was inhibited (45%)
by 10−5 mol/L staurosporine, an inhibitor of PKC, and by 41%
during perfusion with 5 × 10−5 mol/L of the cell Ca2+ chela-
tor bis (2-aminophenoxy) ethane-tetraacetic acid (BAPTA).
In order to study the role of Ca2+-dependent K channels in
the luminal hormonal action, the tubules were perfused with
5 mmol/L tetraethylammonium chloride (TEA) or 10−7 mol/L
iberiotoxin, in the presence of AVP, and JK was significantly re-
duced by both agents. Iberiotoxin reduced AVP-stimulated JK
by 36.4%, and AVP-independent JK (after blocking V1 recep-
tors) by only 16%.
Conclusion. The results suggest that the luminal V1-
receptor effect of AVP on JK was mediated by the phos-
pholipase C (PLC)/Ca2+/PKC signaling path and not by
adenylate cyclase/cAMP/PKA, therefore probably acting on
maxi-potassium channels.
Renal potassium excretion is essential for the home-
ostasis of this ion in the animal body. This excretion
is maintained essentially by secretion along the distal
nephron, particularly along the initial and cortical collect-
ing duct [1]. Potassium secretion depends on a large num-
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ber of factors, including potassium metabolism, sodium
balance, acid-base balance, and hormones such as aldos-
terone and vasopressin, among others.
In a previous work we have observed a luminal ef-
fect of arginine vasopressin (AVP) when cortical distal
tubules were perfused with this hormone at concentra-
tions between 10−11 and 10−9 mol/L. This effect was
mediated by V1 receptors, since it was abolished by
the V1 receptor antagonist (b-mercapto-b-cyclopenta-
methylenepropionyl-o-me-tyr2-arg8 vasopressin), and
not by the V2 receptor antagonist (adamantaneacetyl-
o-et-d-tyr2, val4 aminobutyryl6, arg8,9 vasopressin) [2].
It is known that vasopressin acts on V1 receptors
in vascular smooth muscle cells via phospholipase C
(PLC)/inositol 3,4,5-triphosphate (IP3)/calcium signaling
[3–5]. On the other hand, it was shown that when mi-
crodissected cortical collecting tubules are incubated with
vasopressin, potassium secretion is stimulated by increas-
ing the density of apically active renal outer medullary
K+ channel (ROMK) channels via a cyclic adenosine
monophosphate-protein kinase A (cAMP-PKA) path-
way [6]. This finding is supported by studies on the
thick ascending limb, where treatment with 1-desamino
D-Arg8-vasopressin (dDAVP), a specific V2 agonist, also
increased the density of apical ROMK channels [7]. These
observations suggested that stimulation of potassium se-
cretion by vasopressin might be due to V2 receptor and
cAMP-PKA activation. On the other hand, our data
showing luminal action of vasopressin via V1 receptors
on distal potassium secretion suggest two possibilities.
Either vasopressin is able to stimulate potassium secre-
tion by way of two signaling pathways, starting with V1
and V2 receptors, or V1 activation at the apical cell mem-
brane may stimulate K secretion via the same path of
basolateral V2 receptor activation [i.e., the Gs protein
(adenylate cyclase-cAMP-PKA pathway)].
The present study investigates the mechanism of cell
signaling of the effect of luminal action of 10−11 mol/L
vasopressin via V1 receptors. As will be evidenced be-
low, the alternative of activation of potassium secretion
by the protein kinase C (PKC) path is the preferred
mechanism, but our present evidence together with pre-
vious data from the literature [6, 8], suggests that initial
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Fig. 1. Experimental setup: stationary microperfusion of cortical dis-
tal tubule. Double-barreled micropipette is inserted into late proxi-
mal tubule. Abbreviations are: C, colored castor oil; P, control perfu-
sion solution; S, single micropipette for experimental solution. Double-
barreled microelectrode in late distal tubule (initial collecting duct).
Abbreviations are: IE, ion exchange resin; Ref, reference electrode.
collecting duct cells have both V1 and V2 receptors and
respond to both cAMP (V2) and PKC (V1) mechanisms,
possibly acting on different K+ channels.
METHODS
Male Wistar rats weighing 210 to 300 g were anes-
thetized with inactin, 100 mg/kg, and prepared for in vivo
micropuncture as described previously [2]. Stationary
microperfusion experiments were performed as shown
schematically in Figure 1. A proximal tubule was punc-
tured by a double-barreled micropipette, one barrel be-
ing used to inject FDC-green–colored perfusion solution,
and the other to inject Sudan-black–colored castor oil
used to block the injected fluid columns in the lumen.
The control solution contained 100 mmol/L NaCl, 20
mmol/L Na Hepes, 0.5 mmol/L KCl, 1 mmol/L CaCl2,
and raffinose (added to minimize fluid reabsorption) to
reach an osmolality of 300 mOsm. pH was adjusted to
6.5. This solution contained AVP in the concentrations
given in the Results section, depending on the specific
experiment. A single micropipette containing the same
Ringer solution plus the signaling agent or channel in-
hibitor was impaled in a neighboring loop. A late dis-
tal segment of the same nephron, recognized by the col-
ored perfusion and by having a transepithelial potential
difference (PD) of more than 20 mV, lumen negative,
was impaled by a double-barreled asymmetric microelec-
trode (WPI, Sarasota, FL, USA), the larger barrel con-
taining at its tip, after silanization with hexamethyldis-
ilazane, the potassium-ion sensitive ion-exchange resin
(both from Fluka, Buchs, Switzerland) and the smaller,
0.24 mol/L NaCl and 0.76 mol/L Na acetate, colored by
FDC-green. This potassium-free solution was calculated
to have mean similar cation and anion mobilities. The
microelectrode had a tip diameter of approximately 1
lm, and the reference barrel a resistance of less than
10 MOhm. Additional properties of the microelectrode
were described previously [9]. Standards had a composi-
tion of 3, 10, or 30 mmol/L KCl and 100 mmol/L NaCl
were added to each of these solutions. Decade voltage
difference for K+ ranged from 40 to 45 mV. The elec-
trodes were calibrated before and after every impale-
ment by superfusion of the kidney surface with standards
at 37◦C. Perfusions were performed by air-filled syringes
connected to the micropipette holders by polyethylene
tubing, at a rate sufficient to lower luminal potassium
concentrations to values near those of the perfusion fluid
(i.e., 0.5 mmol/L).
Every tubule was perfused first with control solutions
(AVP-free), then with solutions containing AVP or so-
lutions with AVP and experimental modifiers of trans-
port, allowing for paired measurement of K+ secretion.
By this technique a mean of several (about two to four)
control and experimental curves were obtained, consti-
tuting the pair of values for this tubule. The value of n
given for an experimental condition corresponds to the
number of perfused tubules, approximately one to three
being perfused in one rat. Statistical evaluation was per-
formed by the paired t test, comparing the means of con-
trol and experimental values of every tubule. Details of
the experimental procedure have been given before [2,
10]. The voltage between the microelectrode barrels was
sampled every second by an AD converter (Lynx, Sa˜o
Paulo, Brazil) in a microcomputer (Dell model 333D).
At the same time, the difference between the reference
barrel PD and ground (the rat tail) was recorded, giving
the evolution of transepithelial PD with time during the
perfusion. The data were analyzed by a Visual Basic pro-
gram using the Excel (Microsoft) software. The half-time
(t1/2 ) of the approach of K
+ activities to their stationary
level was obtained, as well as the stationary K+ activity
and PD. Secretory K+ fluxes (JK) were obtained by the
following relationship:
JK+ = ln 2t1/2
(Ks − Ko) ∗ r2 (equation 1)
where t1/2 is the half-time of K
+ activity increase toward
the stationary level, Ks is the stationary K+ activity, Ko is
the initial K+ activity (taken as 0.5 mmol/L), and r is the
tubule radius [9, 11].
Vasopressin, 8-bromo cAMP, phorbol 12-myristate 13
acetate (PMA), H89, staurosporine, and tetraethylam-
monium chloride (TEA) were obtained from Sigma,
St. Louis. BAPTA-AM was obtained from Molecular
Probes, Inc. (Eugene, OR, USA). Iberiotoxin was ob-
tained from Tocris (Ellisville, MO, USA). Other chemical
products were of analytic grade.
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Table 1. Stationary potassium concentrations (Ks) and half-times of K
+ concentration increase toward Ks (t1/2 ) with different agents
[K+]s mmol/L t1/2 seconds
Experiment Control Experiment Control Experiment
8-bromo-cyclic adenosine 29.0 ± 1.72 (13) 29.3 ± 2.43 12.8 ± 0.90 (13) 19.3 ± 2.06a
monophosphate (cAMP)
10−5 mol/L
Phorbol 12-myristate 23.6 ± 1.92 (8) 25.1 ± 1.49 12.4 ± 1.36 (8) 9.9 ± 1.31b
13-acetate (PMA)
10−8 mol/L
aP < 0.01; bP < 0.05 vs. control (paired t test). Mean ± SE.
Table 2. Stationary potassium concentrations (Ks) and half-times of K
+ concentration increase toward Ks (t1/2 ) with different agents, in the
presence of luminal arginine vasopressin (AVP) 10−11 mol/L or AVP receptor 1 antagonist (AV1) 10−6 mol/L
[K+]s mol/L t1/2 seconds
AVP 10−11 mol/L Experiment AVP Experiment
Experiment
AVP + H89 10−4 mol/L 28.4 ± 2.06 (10) 29.2 ± 3.34 14.5 ± 2.37 (10) 17.5 ± 3.27
AVP + stauporsporin 10−5 mol/L 25.4 ± 1.43 (13) 28.1 ± 1.96a 11.6 ± 0.977 (13) 18.2 ± 2.08a
AVP + BAPTA 5 × 10−5M 30.5 ± 3.36 (9) 27.7 ± 2.91 12.9 ± 1.07 (9) 23.5 ± 4.09a
AVP + tetraethylammonium 27.9 ± 2.72 (8) 27.4 ± 2.41 9.2 ± 1.00 (8) 13.1 ± 1.32a
chloride (TEA) 5 mmol/L
AVP + iberiotoxin 10−7 mol/L 19.3 ± 1.88 (7) 17.5 ± 1.70 8.14 ± 1.08 (7) 11.8 ± 1.59a
Luminal perfusion AV1 10−6 mol/L AV1
AV1 + iberiotoxin 10−7 mol/L 23.0 ± 1.78 (14) 21.9 ± 2.34 9.3 ± 0.95 (14) 13.5 ± 1.39a
BAPTA, bis aminophenoxy ethane-tetraacetic acid.
aP < 0.05 vs. AVP 10−11 or AV1 10−6 mol/L (paired t test). Mean ± SE.
Statistical comparisons were made by the paired t
test, taking the probability of 0.05 (5%) as the limit of
significance.
RESULTS
Tables 1 and 2 give the basic data from which rates of
potassium secretion were calculated according to equa-
tion 1 [i.e., stationary potassium concentrations (Ks) and
half-times of the approach of luminal K+ levels to the
stationary concentrations (t1/2 )]. It is noted that the dif-
ferences between experimental groups are mostly due to
modifications in t1/2 rather than in Ks, that is, the criti-
cal value is the rate at which the luminal K+ level ap-
proaches its steady-state. Table 3 gives the transepithelial
PD for the experiments performed in this series. Most of
mean PD values show no significant differences between
groups.
In the following, we will present mean potassium secre-
tion rates for the different experimental conditions stud-
ied in this work. Mean values for the different groups are
given in Table 4. In Figure 2 and Table 4, it is noted that
luminal perfusion with 10−5 mol/L 8-bromo-cAMP re-
duces K+ secretion significantly, by 14%, indicating that
cAMP at the applied level does not increase but reduces
potassium transport by this tubule segment. During lumi-
nal perfusion with 10−8 mol/L PMA, an activator of PKC,
K+ secretion is increased markedly, by 35%, with PMA
(see Fig. 2B). When 10−4 mol/L H89, an inhibitor of the
Table 3. Transepithelial PD (mV) in late distal tubule during
perfusion with different agents
Experimental
Luminal perfusion Control PD
8 bromo-cyclic adenosine −52.8 ± 3.24 (16) −53.3 ± 4.15
monophosphate (cAMP)
10−5 mol/L
Phorbol 12-myristate −53.9 ± 6.57 (8) −52.1 ± 6.45
13-acetate (PMA)
10−8 mol/L
Arginine vasopressin Experimental
(AVP) 10−11 mol/L PD
AVP + H89 10−4 mol/L −41.6 ± 3.68 (10) −37.3 ± 4.16
AVP + staurosporin 10−5 mol/L −49.9 ± 4.53 (13) −39.6 ± 5.39a
AVP + BAPTA 5 × 10−5 mol/L −44.8 ± 2.94 (12) −42.3 ± 3.46
AVP + tetraethylammonium −38.9 ± 4.97 (8) −42.1 ± 4.53
chloride (TEA) 5 mmol/L
AVP + iberiotoxin 10−7 mol/L −37.5 ± 4.02 (7) −35.9 ± 3.89
Experimental
AV1 10−6 mol/L PD
AV1 + iberiotoxin 10−7 mol.L 39.0 ± 3.14 (14) 36.5 ± 3.52
BAPTA, bis aminophenoxy ethane-tetraacetic acid; PD, potential difference.
aP < 0.05 against control (10−11 mol/L AVP) (paired t test). Mean ± SE.
action of PKA, is added to luminal AVP (see Fig. 3A), no
change in K+ secretion is observed, supporting the view
that AVP action is not dependent on the activity of the
cAMP/PKA pathway. Figure 3B shows that 10−5 mol/L
staurosporine, an inhibitor of PKC, abolishes the stim-
ulatory effect of AVP on K+ secretion, reducing JK by
41% when staurosporine was perfused. Taken together,
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Table 4. Rates of potassium secretion (JK), nmol/cm−2.seconds −1 in
late distal tubule (initial collecting duct) during luminal perfusion with
different agents
Luminal perfusion Control Experimental
8-bromo-cyclic adenosine 0.74 ± 0.035 (13) 0.64 ± 0.053a
monophosphate (cAMP)
10−5 mol/L
Phorbol 12-myristate 0.71 ± 0.05 (8) 0.96 ± 0.08b
13-acetate (PMA)
10−8 mol/L
Arginine vasopressin
(AVP) 10−11 mol/L Experimental
AVP + H89 10−4 mol/L 0.88 ± 0.08 (9) 0.89 ± 0.10
AVP + staurosporin 10−5 mol/L 0.91 ± 0.08 (12) 0.50 ± 0.15b
AVP + BAPTA 5 × 10−5 mol/L 0.87 ± 0.084 (9) 0.52 ± 0.04c
AVP + tetraethylammonium 1.04 ± 0.073 (7) 0.72 ± 0.084b
chloride (TEA) 5 mmol/L
AVP + iberiotoxin 10−7 mol/L 0.93 ± 0.056 (7) 0.59 ± 0.051b
AV1 10−6 mol/L Experimental
AV1 + iberiotoxin 10−7 M 0.76 ± 0.018 (14) 0.64 ± 0.060a
Control, 10−11 mol/L AVP or 10−6 mol/L AV1 (V1 receptor antagonist)
(paired t test). aP < 0.05; bP < 0.01; cP < 0.001.
these experiments indicate that the PLC/IP3/PKC signal-
ing path probably mediates the action of luminal AVP on
potassium transport.
Figure 4 and Table 4 show that luminal perfusion with
AVP plus 10−5 mol/L BAPTA-am, an intracellular cal-
cium chelator known to reduce cell Ca2+ levels [12, 13],
blocked the luminal action of AVP, reducing JK by 40.2%,
indicating that cell calcium plays an important role in the
action of the hormone. It is interesting to observe that the
value of JK after staurosporin and after BAPTA are very
similar, showing that in both situations the stimulating
effect of AVP was blocked to the same extent, which is
suggestive of action of these agents on the same signaling
path.
It has been shown that the most important channels
for distal K+ secretion are the small conductance chan-
nels, the ROMK channels [14, 15]. These channels are
not directly Ca2+-dependent, as opposed to our findings
for the luminal AVP effect (see above); on the other
hand, the voltage-dependent maxi-potassium channels,
of large conductance (70 to 120 pS), which have been
found in a large number of cells, including renal epithe-
lial cells [16–18], are Ca2+-dependent. These channels are
blocked by TEA. Figure 5 shows that 5 mmol/L TEA sig-
nificantly inhibits K+ secretion in the presence of lumi-
nal AVP, reducing JK measured in the presence of AVP,
by 31%. This suggests that Ca2+-dependent K+ channels
might participate in distal potassium secretion, being re-
sponsible for the action of the hormone on this trans-
port mechanism. This hypothesis was strengthened by
the use of a more specific inhibitor of Ca2+-dependent
K+ channels, iberiotoxin, which reduced the effect of lu-
minal AVP by 36.6% (see Fig. 6A) (Table 4). This toxin, in
Fig. 2. Potassium secretory flux (JK) during luminal perfusion with
10−5 mol/L 8-bromo-cyclic adenosine monophosphate (cAMP) (A) and
with 10−8 mol/L phorbol 12-myristate 13-acetate (PMA) (B). 8-bromo-
cAMP reduces JK, while PMA, known to stimulate protein kinase C
(PKC), increases JK significantly. ∗P < 0.05; ∗∗P < 0.01.
the same way as charybdotoxin, both derived from scor-
pion venom, has been shown to block these channels with
great specificity [19]. Figure 6B shows studies investigat-
ing the effect of iberiotoxin on AVP-independent potas-
sium secretion. For this purpose, tubules were perfused
with a blocker of V1 receptors for AVP (b-mercapto-b-
b-cyclopenta-methylenepropionyl1,O-Me-Tyr2-Arg8 va-
sopressin) (AV1), which was used since endogenous AVP
may affect basal K+ secretion [2]. It is noted that the ef-
fect of iberiotoxin observed during these perfusions is
much smaller (JK (AV1) − JK (AV1 + IBX) = 0.13 ±
0.063 nmol.cm−2.seconds−1) than that found in the ex-
periments with luminal perfusion with AVP 10−11 mol/L
(JK = 0.34 ± 0.074). These findings indicate that Ca2+-
dependent potassium channels very probably are the site
at which AVP stimulates K+ secretion by initial collecting
duct.
DISCUSSION
A number of experimental reports have shown that
potassium secretion by distal nephron segments is stimu-
lated by AVP [20–22]. In spite of marked reduction in
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Fig. 3. JK during luminal perfusion with 10−11 mol/L arginine vaso-
pressin (AVP), alone or with 10−4 mol/L H89, (A) or with 10−5 mol/L
staurosporin (B). Note that H89, a blocker of protein kinase A (PKA),
does not affect JK, while staurosporin, a blocker of protein kinase C
(PKC), causes a significant reduction of JK. #P < 0.01.
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Fig. 4. JK during luminal perfusion with 10−11 mol/l arginine vaso-
pressin (AVP) alone or plus 10−11 mol/L BAPTA-am. BAPTA, a cal-
cium chelator, reduces JK, indicating that the effect of AVP depends on
cell Ca2+. #P < 0.001. BAPTA, bis aminophenoxy ethane-tetraacetic
acid.
urine flow during venous infusion of AVP in Brattle-
boro rats, fractional K+ excretion increased by 77%; in
free-flow micropuncture performed in these rats it was
shown that this increase occurred beyond the late distal
tubule, but it was significant in microperfused cortical dis-
tal tubules (initial collecting duct) [20]. Pretreatment with
deoxicorticosterone has been shown to enhance the AVP
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Fig. 5. JK during luminal perfusion with 10−11 mol/L arginine vaso-
pressin (AVP) alone and plus 5 mmol/L tetraethylammonium chloride
(TEA), a blocker of Ca2+-dependent K+ channels (maxi-potassium).
∗P < 0.05.
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Fig. 6. JK during luminal perfusion with 10−11 mol/L arginine vaso-
pressin (AVP) alone or plus 10−7 mol/L iberiotoxin (IBX), a scorpion
venom-derived toxin, highly specific inhibitor of maxi-potassium chan-
nels (A). (B) luminal perfusion with AV1, blocker of V1 receptors for
AVP, alone or with iberiotoxin. ∗P < 0.05; ∗∗P < 0.01.
effect in the rat cortical collecting duct perfused in vitro.
Under these conditions, AVP caused a fourfold increase
in net sodium reabsorption and a threefold increase in
net potassium secretion [21]. An effect of AVP on potas-
sium transport, however, was not found in isolated per-
fused collecting duct of the rabbit [22]. In addition, bath
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to lumen unidirectional fluxes of 86Rb+ in isolated per-
fused rat cortical collecting duct increased by approxi-
mately 180% when 100 lU/mL of AVP were added to
the bathing solution [23]. These findings indicated that
AVP was able to exert a significant stimulating effect on
potassium transport in rat cortical collecting duct.
The mechanism by which this effect of AVP occurs has
been investigated. It has been proposed that AVP acted
by increasing the electrochemical driving force for K+
across the apical cell membrane [24]. However, our ob-
servations that in most situations no significant changes in
the stationary potassium concentration in the lumen and
of transepithelial PD were observed argue in favor that
the electrochemical potential difference for K+ across the
apical membrane (assuming constant cell K+ during the
short experimental period) is probably not the determin-
ing factor for the differences in K+ secretion found in
these experiments. This finding is compatible with data
showing that the density of low-conductance (ROMK)
potassium channels at the apical membrane of principal
cells of rat cortical collecting duct measured by the patch-
clamp technique increased when 10−10 mol/L AVP was
added to the solution bathing split-open tubules [6]. An
increase of the density of apical channels would be equiv-
alent to a higher apical potassium conductance and to a
reduction of the half-time of potassium equilibration in
the tubule lumen as shown in our experiments.
The patch-clamp study on ROMK channels cited above
indicated that dibutiryl cAMP and forskolin also in-
creased channel density, suggesting that the effect of
AVP on these channels was mediated by adenylate cy-
clase/cAMP/PKA, a signaling path that has been shown
to mediate the increase in water permeability induced by
this hormone [25]. This path is dependent on V2 recep-
tors of AVP, present on the basolateral cell membrane,
which is apparently incompatible with our finding of V1
receptor dependence of the apical membrane effect of
AVP [2, 26]. The latter effect is more compatible with
V1 mediated action of AVP, which has been shown in
vascular smooth muscle cells and which is mediated by
cell Ca2+ and PKC [3]. This V1-mediated effect has been
found, in vascular smooth muscle, at AVP concentrations
down to 10−11 mol/L, and has been blocked by PKC in-
hibitors such as staurosporine, which abolished the Ca2+
spiking seen in these cells caused by AVP [3]. Actually,
about 20% of total AVP receptors in cortical collecting
duct are of the V1 type, which should then constitute
an important mechanism of AVP action in this structure
[27]. Our data show that the luminal action of AVP is
mediated by V1 receptors, and is signaled by the PLC-
IP3/Ca2+-diacyglycerol (DAG)-PKC system. This path is
suggested by several of our results. First, 8-bromo-cAMP,
a liposoluble analogue of cAMP, does not stimulate K+
secretion, but actually reduces it; it has been shown that
elevated levels of cAMP may decrease cell Ca2+ levels
by stimulating the action of Ca2+-ATPase of sarcoplas-
mic reticulum and of the plasma membrane Ca2+/Na+
exchanger, which may reduce the V1-receptor mediated
action of AVP [28, 29]. In addition, the PKA inhibitor
H89 (10−4 mol/L), in the presence of 10−11 mol/L AVP,
did not affect K+ secretion, indicating that PKA was no
part of the stimulatory mechanism of AVP on this process.
Another signaling cascade that may be active in the V1
effect of AVP is the PLC/PKC cascade. As mentioned
above, this is the cascade involved in the action of AVP
via V1 receptors in vascular smooth muscle [3]. PMA,
10−8 mol/L, which is a PLC stimulating agent, had a sig-
nificant stimulating effect on distal K+ secretion. On the
other hand, the PKC inhibitor staurosporine 10−5 mol/L
caused a marked reduction of K+ secretion in the pres-
ence of 10−11 mol/L AVP, suggesting a role for PKC in
AVP action. The PLC/IP3/PKC path is also known to in-
volve an increase in cell Ca2+, which acts as a second mes-
senger and activates PKC by transferring cytosolic PKC
to the cell membrane [4, 30, 31]. In order to investigate if
this messenger might be also active in luminal AVP func-
tion, tubules were perfused with AVP plus 10−5 mol/L
BAPTA-am, an intracellular calcium chelator known to
reduce cell Ca2+ levels [13]. A significant reduction of K+
secretion was observed, indicating a dependence of this
transport on the cellular calcium level. Taking these ob-
servations together, they suggest that the most important
signaling path for the luminal effect of AVP on potassium
secretion is the PLC/PKC/Ca2+ system, which is compat-
ible with the known path related to the V1 receptors of
AVP in other tissues such as vascular smooth muscle cells.
Our findings of potassium secretion signaling via the
PKC path are apparently at variance with a number of
studies on K+ channels. We have shown before that the
action of AVP on potassium secretion is due to an ef-
fect of this hormone on K+ channels, and not on the
KCl-cotransport mechanism, which has been localized
to the apical cell membrane of the late distal tubule [2,
10]. We have mentioned above that there is evidence
for cAMP/PKA-mediated regulation of the apical den-
sity of low conductance (ROMK) channels [6]. It was
referred, also, that PKC or phorbol ester inhibit these
channels, and that an increase in cell calcium decreases
their activity [8, 32]. These findings are compatible with
the presence of phosphorylation sites for PKA and
PKC on the cytoplasmic COOH-terminus of the ROMK
molecule [33]. However, it must be taken into consid-
eration that the described studies were performed with
the patch-clamp technique, and are specific for the low-
conductance potassium channel. It has been considered
that these are the channels responsible for most of the
apical potassium secretory mechanism [14]. However,
other potassium channels have been found at this site,
and particularly the calcium and voltage dependent large
(or medium) conductance channel has been described
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and might have an important role in potassium secretion.
Early investigations detected the presence of these chan-
nels in cultured chicken kidney cells [34] and in rabbit
cortical collecting duct [35]. In the cultured cells, it was
found that AVP stimulated the activity of these channels
[34]. Madin-Darby canine kidney (MDCK) cells (cul-
tured distal renal cells) have also been shown to have
maxi-potassium channels at their apical surface by the
patch-clamp technique. These channels depended on Ca+
and were regulated by PKC, since they were markedly
stimulated by phorbol ester [36]. These channels have a
low open probablity at normal calcium and cell poten-
tial; however, agents such as angiotensin and AVP in-
crease cell calcium [37, 38]. In addition, late distal tubule
and cortical collecting duct have partly depolarized api-
cal cell membranes, mostly due to the presence of EnaC
sodium channels. More recently, it was shown that these
K+ channels were in large part responsible for the flow-
dependent increase in potassium secretion, both in adult
and in developing rats [39].
A number of inhibitors for the maxi-potassium chan-
nels have been described. TEA has been shown repeat-
edly to reduce the open probability of these channels
[33], but the specificity of TEA toward maxi-potassium
channels is limited. More recently, toxins derived from
scorpion venom such as charybdotoxin and iberiotoxin
have been used [40]. Charybdotoxin was used to isolate
and purify the high-conductance, Ca++ dependent (maxi-
potassium) potassium channel [41]. Iberiotoxin has been
shown to be even more specific for Ca2+ dependent
K+ channels, since charybdotoxin has also an effect on
ROMK potassium channels [42]. Iberiotoxin is referred
to be more potent than charybdotoxin in oocytes trans-
fected with maxi-potassium channels [43]; it is also re-
ferred to block maxi-potassium channels at their extra-
cellular mouth, in the same way as TEA [44].
The observations discussed above and our data with
TEA and iberiotoxin suggest that the channels stim-
ulated by AVP in our experiments are probably the
high-conductance, Ca2+ and voltage-dependent potas-
sium channels, in general called maxi- (or midi-) potas-
sium channels, with a conductance of 70 to 100 pS. They
are sensitive to vasoconstrictor concentrations of AVP
interacting with the V1 receptor in smooth muscle cells
(10−11 to 10−10 mol/L), via the PKC system. PKC involves
a number of isoforms; it was shown that PKC a and d are
those most involved in the epithelial action of AVP [3].
Of course, our present data do not permit to distinguish
between these isoforms. Our results have also confirmed
(see Fig. 6) that in the absence of stimulation by AVP, that
is, in the presence of a V1 receptor antagonist, the partic-
ipation of these maxi-potassium channels in K+ secretion
is minor, while most of the AVP dependent increase in
K+ secretion is mediated by Ca2+-dependent maxi-K+
channels.
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Fig. 7. Schematic drawing of cell signaling mechanisms of luminal (V1
receptors) and basolateral (V2 receptors) action of arginine vasopressin
(AVP). The role of V1 receptors and their signaling are derived from the
present studies. The role of V2 receptors in ROMK channel stimulation
is based on the studies of Cassola, Giebisch, and Wang [6].
On the basis of our experimental results and data from
the literature, Figure 7 shows in a schematic way the
main signaling paths for the action of AVP on potas-
sium transport in initial collecting duct cells of the kidney.
The first mechanism described for AVP action on JK in-
volves basolateral V2 receptors, in a way similar to the
effect on water permeability [6]. AVP stimulates V2 re-
ceptors, which activate Gs protein, which in turn activates
adenylyl cyclase to liberate cAMP, leading to activation
of PKA and of the low conductance potassium channel
(ROMK). On the other hand, according to our own data,
AVP may also stimulate luminal V1 receptors, which acti-
vate protein Gq, then PLC and the path phosphoinositol
diphosphate (PIP2), IP3, liberation of Ca2+, or PLC-PIP2-
DAG-PKC, both ways leading to activation of the apical
maxi-potassium channels [2, 3]. This alternative explains
why potassium channels may be activated both by PKA
and PKC pathways, and how different effects may be ob-
served with basolateral and apical stimulation. This de-
scription is compatible with the action of AVP on both
low and high conductance potassium channels, and with
involvement of V1 (apical membrane) and V2 (basolat-
eral membrane) receptors in distal nephron potassium
secretion [45–49].
What could be the physiologic role of the observed
stimulation of K+ secretion by AVP? It is well known
that K+ transport across the distal tubule epithelium
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depends markedly on the rate of fluid flow along the
tubule, increasing at high flow and decreasing at reduced
flow [39, 50]. When animals are dehydrated or their ex-
tracellular volume is depleted, urine flow is markedly re-
duced and plasma and urine AVP levels are increased
[51]. Under these conditions, the reduction of K+ secre-
tion caused by the diminished urine flow would be com-
pensated by the stimulating action of AVP, contributing
to maintain the potassium balance of the body.
ACKNOWLEDGMENTS
The authors thank Dr. Gerhard Giebisch for helpful suggestions and
comments. This work was supported by grants and fellowships from
Fundac¸a˜o de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP,
99/12866–3), Conselho Nacional de Desenvolvimento Cientifico e Tec-
nologico (CNPq and Pronex 61.1029/1998–0).
Reprint requests to Dr. Gerhard Malnic, Departmento Fisiologia e
Biofisica, Inst. Cieˆncias Biome´dicas USP, Av. Prof. Lineu Prestes 1524,
05508–900 Sa˜o Paulo, Brazil.
E-mail: gemalnic@usp.br
REFERENCES
1. GIEBISCH G, MALNIC G, BERLINER RW: Control of renal potassium
excretion (chapter. 10), in The Kidney, 6th ed., edited by Brenner
BM, Philadelphia, WB Saunders, 2000, pp 417–454
2. AMORIM JB, MALNIC G: V(1) receptors in luminal action of va-
sopressin on distal K(+) secretion. Am. J Physiol Renal Physiol
278:F809–F816, 2000
3. FAN J, BYRON KL: Ca2+ signalling in rat vascular smooth muscle
cells: A role for protein kinase C at physiological vasoconstrictor
concentrations of vasopressin. J Physiol 524 (Pt 3):821–831, 2000
4. ISHIBASHI T, YOSHIDA Y, IMAI S, NISHIO M: IP3 production in A10
cells, an established aortic smooth muscle cultured cell line: Effects
of agonist administration procedure and culture conditions. Gen
Pharmacol 32:115–121, 1999
5. LI Y, SHIELS AJ, MASZAK G, BYRON KL: Vasopressin-stimulated
Ca2+ spiking in vascular smooth muscle cells involves phospholi-
pase D. Am J Physiol Heart Circ.Physiol 280:H2658–H2664, 2001
6. CASSOLA AC, GIEBISCH G, WANG W: Vasopressin increases density
of apical low-conductance K+ channels in rat CCD. Am J Physiol
Renal Fluid Electrolyte Physiol 264:F502–F509, 1993
7. ECELBARGER CA, KIM GH, KNEPPER MA, et al: Regulation of potas-
sium channel Kir 1.1 (ROMK) abundance in the thick ascending
limb of Henle’s loop. J Am Soc Nephrol 12:10–18, 2001
8. WANG W, GIEBISCH G: Dual modulation of renal ATP-sensitive
K+ channel by protein kinases A and C. Proc Natl Acad Sci USA
88:9722–9725, 1991
9. VESTRI S, MALNIC G: Mechanism of potassium transport across prox-
imal tubule epithelium in the rat. Brazilian J Med Biol Res 23:1195–
1199, 1990
10. AMORIM JBO, BAILEY MA, MUSA-AZIZ R, et al: Role of luminal
anion and pH in distal tubule potassium secretion. Am J Physiol
Renal Physiol 284:F381–F388, 2003
11. FERNANDEZ R, LOPES MJ, LIRA RF, et al: Mechanism of acidification
along cortical distal tubule of the rat. Am J Physiol 266:F218–F226,
1994
12. STUART RO, SUN A, PANICHAS M, et al: Critical role of intracellular
calcium in tight junction biogenesis. J Cell Physiol 159:423–433, 1994
13. YIP KP: Coupling of vasopressin-induced intracellular Ca(2+) mo-
bilization and apical exocytosis in perfused rat kidney collecting
duct. J Physiol 538:891–899, 2002
14. BOIM MA, HO K, SHUCK ME, et al: ROMK inwardly rectifying ATP-
sensitive K+ channel. II. Cloning and distribution of alternative
forms. Am J Physiol Renal Fluid Electrolyte Physiol 268:F1132–
F1140, 1995
15. KOHDA Y, DING W, PHAN E, et al: Localization of the ROMK potas-
sium channel to the apical membrane of distal nephron in rat kidney.
Kidney Int 54:1214–1223, 1998
16. LATORRE R, OBERHAUSER A, LABARCA P, ALVAREZ O: Varieties of
calcium-activated potassium channels. Ann Rev Pharmacol 51:385–
400, 1989
17. VERGARA C, LATORRE R, MARRION NV, ADELMAN JP: Calcium-
activated potassium channels. Curr Opin Neurobiol 8:321–329, 1998
18. WANG SX, IKEDA M, GUGGINO WB: The cytoplasmic tail of large
conductance, voltage- and Ca2+-activated K+ (MaxiK) channel is
necessary for its cell surface expression. J Biol Chem 278:2713–2722,
2003
19. CANDIA S, GARCIA ML, LATORRE R: Mode of action of iberiotoxin, a
potent blocker of the large conductance Ca-2+-activated K+ chan-
nel. Biophys J 63:583–590, 1992
20. FIELD MJ, STANTON BA, GIEBISCH GH: Influence of ADH on renal
potassium handling: A micropuncture and microperfusion study.
Kidney Int 25:502–511, 1984
21. TOMITA K, PISANO JJ, KNEPPER MA: Control of sodium and potas-
sium transport in the cortical collecting duct of the rat: Effects
of bradykinin, vasopressin and deoxycorticossterone. J Clin Invest
76:132–136, 1985
22. HOLT WF, LECHENE C: ADH–PGE2 interactions in cortical col-
lecting tubule. I. Depression of sodium transport. Am J Physiol
241:F452–F460, 1981
23. SCHAFER JA, TROUTMAN SL: Effect of ADH on rubidium transport
in isolated perfused rat cortical collecting tubules. Am J Physiol
250:F1063–F1072, 1986
24. SCHAFER JA, TROUTMAN SL, SCHLATTER E: Vasopressin and miner-
alocorticoid increase apical membrane driving force for K+ secre-
tion in rat CCD. Am J Physiol 258:F199–F210, 1990
25. BROWN D: The ins and outs of aquaporin-2 trafficking. Am J Physiol
Renal Physiol 284:F893–F901, 2003
26. PROMENEUR D, KWON TH, FROKIAER J, et al: Vasopressin V(2)-
receptor-dependent regulation of AQP2 expression in Brattleboro
rats. Am J Physiol Renal Physiol 279:F370–F382, 2000
27. AMMAR A, ROSEAU S, BUTLEN D: Pharmacological characterization
of V1a vasopressin receptors in the rat cortical collecting duct. Am
J Physiol 262:F546–F553, 1992
28. LEMOS VS, BUCHER B, TAKEDA K: Neuropeptide Y modulates
ATP-induced increases in internal calcium via the adenylate cy-
clase/protein kinase A system in a human neuroblastoma cell line.
Biochem J 321:439–444, 1997
29. YAEKURA K, YADA T: [Ca2+]i-reducing action of cAMP in rat pan-
creatic beta-cells: Involvement of thapsigargin-sensitive stores. Am
J Physiol 274:C513–C521, 1998
30. DIBAS AI, REZAZADEH SM, VASSAN R, et al: Mechanism of
vasopressin-induced increase in intracellular Ca2+ in LLC-PK1
porcine kidney cells. Am J Physiol Cell Physiol 272:C810–C817,
1997
31. HATTON GI, BICKNELL RJ, HOYLAND J, et al: Arginine vasopressin
mobilises intracellular calcium via V1-receptor activation in astro-
cytes (pituicytes) cultured from adult rat neural lobes. Brain Res
588:75–83, 1992
32. WANG W-H, GEIBEL J, GIEBISCH G: Mechanism of apical K+ channel
modulation in principal renal tubule cells. Effect of inhibition of
basolateral Na+-K+-ATPase. J Gen Physiol 101:673–694, 1993
33. WANG WH, HEBERT SC, GIEBISCH G: Renal K+ channels: Structure
and function. Annu Rev Physiol 59:413–436, 1997
34. GUGGINO SE, SUAREZ-ISLA BA, GUGGINO WB, SACKTOR B: Forskolin
and antidiuretic hormone stimulate a Ca2+ -activated K+ channel
in cultured kidney cells. Am J Physiol 249:F448–F455, 1985
35. HUNTER M, LOPES AG, BOULPAEP E, GIEBISCH G: Regulation of
single potassium ion channels from apical membrane of rabbit col-
lecting tubule. Am J Physiol 251:F725–F733, 1986
36. WULF A, SCHWAB A: Regulation of a calcium-sensitive K+ channel
(cIK1) by protein kinase C. J Membr Biol 187:71–79, 2002
37. OLIVEIRA-SOUZA M, MELLO-AIRES M: Effect of arginine vasopressin
and ANP on intracellular pH and cytosolic free [Ca2+] regulation
in MDCK cells. Kidney Int 60:1800–1808, 2001
38. OLIVEIRA-SOUZA M, MALNIC G, MELLO-AIRES M: Atrial natriuretic
peptide impairs the stimulatory effect of angiotensin II on H+-
ATPase. Kidney Int 62:1693–1699, 2002
704 Amorim et al: Signaling of AVP and renal K+
39. WODA CB, MIYAWAKI N, RAMALAKSHMI S, et al: Ontogeny of flow-
stimulated potassium secretion in rabbit cortical collecting duct:
Functional and molecular aspects. Am J Physiol Renal Physiol
285:F629–F639, 2003
40. GALVEZ A, GIMENEZ-GALLEGO G, REUBEN JP, et al: Purification
and characterization of a unique, potent, peptidyl probe for the
high conductance calcium-activated potassium channel from venom
of the scorpion Buthus tamulus. J Biol Chem 265:11083–11090,
1990
41. GARCIA ML, KNAUS H-G, MUNUJOS P, et al: Charybdotoxin and its
effects on potassium channels. Am J Physiol Cell Physiol 269:C1–
C10, 1995
42. GARCIA ML, GALVEZ A, GARCIA-CALVO M, et al: Use of toxins to
study potassium channels. J Bioenerg Biomembr 23:615–646, 1991
43. GRIBKOFF VK, LUM-RAGAN JT, BOISSARD CG, et al: Effects of
channel modulators on cloned large-conductance calcium-activated
potassium channels. Mol Pharmacol 50:206–217, 1996
44. GIANGIACOMO KM, GARCIA ML, MCMANUS OB: Mechanism of
iberiotoxin block of the large-conductance calcium-activated potas-
sium channel from bovine aortic smooth-muscle. Biochemistry
31:6719–6727, 1992
45. NONOGUCHI H, OWADA A, KOBAYASHI N, et al: Immunohistochem-
ical localization of V2 vasopressin receptor along the nephron and
functional role of luminal V2 receptor in terminal inner medullary
collecting ducts. J Clin Invest 96:1768–1778, 1995
46. YOSHITOMI K, NARUSE M, HANAOKA K, et al: Functional characteri-
zation of vasopressin V1 and V2 receptors in the rabbit renal cortical
collecting duct. Kidney Int 49:S177–S182, 1996
47. BARRETO-CHAVES ML, DE MELLO-AIRES M: Luminal arginine va-
sopressin stimulates Na+-H+ exchange and H+-ATPase in cortical
distal tubule via V1 receptor. Kidney Int 52:1035–1041, 1997
48. WHEATLEY M, HAWTIN SR, YARWOOD NJ: Structure/function stud-
ies on receptors for vasopressin and oxytocin. Adv Exp Med Biol
449:363–365, 1998
49. MUSA-AZIZ R, BARRETO-CHAVES ML, MELLO-AIRES M: Peritubular
AVP regulates bicarbonate reabsorption in cortical distal tubule
via V(1) and V(2) receptors. Am J Physiol Renal Physiol 282:F256–
F264, 2002
50. MALNIC G, BERLINER RW, GIEBISCH G: Flow dependence of K+
secretion in cortical distal tubules of the rat. Am J Physiol 256:F932–
F941, 1989
51. MOSES A, STECIAK E: Urinary and metabolic clearances of argi-
nine vasopressin in normal subjects. Am J Physiol 251:R365–R370,
1986
